ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more
PRPH is expected to report earnings to rise 15.38% to -15 cents per share on August 07
Q2'25
Est.
$-0.15
Q1'25
Beat
by $0.05
Q4'24
Missed
by $1.62
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.25
The last earnings report on May 20 showed earnings per share of -12 cents, beating the estimate of -18 cents. With 714.72K shares outstanding, the current market capitalization sits at 116.75M.